Keywords: گلیکوزآمینوگلیکان; GAG; Glycosaminoglycan; HA; Hyaluronic Acid; CS; Chondroitin Sulfate; DS; Dermatan Sulfate; HS; Heparan Sulfate; HIV; Human Immunodeficiency Virus; gp120; Glycoprotein 120; CD4; Cluster of Differentiation 4; AMAC; 2-Aminoacridone; DMSO; Dimethyl Sulfoxide
مقالات ISI گلیکوزآمینوگلیکان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گلیکوزآمینوگلیکان; Multiple sulfatase deficiency; Leukodystrophy; Mucopolysaccharidoses; Consensus; Therapy; Care; Outcomes; Prevention; ACC; augmentative and alternative communication; AEP; auditory evoked potential; BiPAP; bilevel positive airway pressure; CPAP; continuou
Keywords: گلیکوزآمینوگلیکان; biomarkers; disease progression; mucopolysaccharidosis type III B; prospective study; BSID-III; Bayley Scales of Infant Development, Third Edition; CHQ-PF50; Child Health Questionnaire Parent Form, 50 items; CSF; Cerebrospinal fluid; DQ; Development quoti
Keywords: گلیکوزآمینوگلیکان; Extracellular matrix; Cornea; Corneal organ culture; Confocal fluorescence microscopy; Stroma; F-actin; filamentous actin; Sulf1; sulfatase 1; LOX1; lysyl oxidase; SMA; smooth muscle actin; TGF-beta1; transforming growth factor beta 1; GAG; glycosaminogly
Keywords: گلیکوزآمینوگلیکان; Fucosylated chondroitin sulfate; Glycosaminoglycan; Anticoagulant activity; Heparin cofactor II; Intrinsic factor Xase complex;
Keywords: گلیکوزآمینوگلیکان; Fucosylated chondroitin sulfate; Glycocluster; Glycosaminoglycan; Anticoagulant; Carbohydrate;
Keywords: گلیکوزآمینوگلیکان; CP; Core protein; ECM; Extracellular matrix; (e)WLC; (extensible) worm-like chain; GAG; Glycosaminoglycan; PG; Proteoglycan; IFM; Interfibrillar matrix; SDF; Small diameter fibril; TC; Tropocollagen; Multi-scale modeling; Soft fibrous tissues; Fatigue;
Keywords: گلیکوزآمینوگلیکان; Glycosaminoglycan; Polyelectrolyte complex nanoparticle; Growth factors; Neural stem cell; Hydrogel; Brain;
Keywords: گلیکوزآمینوگلیکان; Apo; apolipoprotein; BPsys; systolic blood pressure; CS; chondroitin sulfate; CVD; cardiovascular disease; DS; dermatan sulfate; EDTA; ethylene diamine tetraacetic acid; GAG; glycosaminoglycan; HS; heparan sulfate; HSBGF; heparan sulfate-binding growth fa
Keywords: گلیکوزآمینوگلیکان; ACKR; atypical chemokine receptor; ADAM; a disintegrin and metalloprotease; [Ca2+]i; intracellular calcium concentration; CTAP-III; connective tissue-activating peptide III; DPP4; dipeptidyl peptidase 4; ERK; extracellular signal-regulated kinase; GAG; gl
Keywords: گلیکوزآمینوگلیکان; Glycosaminoglycan; Heparan sulfate; Hydrophilic interaction chromatography; Mass spectrometry; Prostate cancer; Tissue microarray;
Keywords: گلیکوزآمینوگلیکان; Glycosaminoglycan; Chondroitin sulfate; Structure-activity relationships; Protein interactions;
Keywords: گلیکوزآمینوگلیکان; Glycosaminoglycan; Heparin; Photocaging; Anticoagulant;
Keywords: گلیکوزآمینوگلیکان; CS; chitosan; GAG; glycosaminoglycan; DDA; degree of deacetylation; ECM; extracellular matrix; FFSA; 5-formyl-2-furansulfonic acid; BZ1S; 2-formylbenzene sulfonic acid; BZ2S; 4-formyl-1,3-benzenedisulfonic acid; APTT; activated partial thromboplastin time
Keywords: گلیکوزآمینوگلیکان; Aβ; amyloid beta; AβPP; amyloid-β precursor protein; AD; Alzheimer's disease; BBB; blood-brain barrier; C6ST1; chondroitin-6-sulfate transferase-1; CathD; cathepsin D; ChABS; chondroitinase ABC; ChGn-1; CS-beta-1,4,N-acetylgalactosaminyltransferase-1;
Keywords: گلیکوزآمینوگلیکان; Glycomic Code; Extracellular matrix; Cell wall; Polysaccharides; Cellulose; Glycosaminoglycan; Hemicellulose; Xyloglucan;
Keywords: گلیکوزآمینوگلیکان; siRNA; Polyethylenimine; Polymeric nanoparticle; Heparin; Glycosaminoglycan; Polynucleotide delivery; Molecular dynamics;
Keywords: گلیکوزآمینوگلیکان; aa; amino acid; ADMA; asymmetric dimethylarginine; AF; atrial fibrillation; ALP; alkaline phosphatase; BMI; body mass index; BMP; bone morphogenetic protein; Cys; cysteine; CAD; coronary artery disease; CKD; chronic kidney disease; CRD; cysteine rich doma
Keywords: گلیکوزآمینوگلیکان; VEGF; vascular endothelial growth factor; BMP; bone morphogenetic protein; TGF-β; transforming growth factor beta; b-FGF; basic fibroblast growth factor; GDF; growth and differentiation factor; PDGF; platelet derived growth factor; MMP; matrix metallopro
Keywords: گلیکوزآمینوگلیکان; CCK-8; cell counting kit-8; DAPI; 4,6-diamidino-2-phenylindole; DMEM; dulbecco's modified Eagle's medium; D-MTJ; decellularized myotendinous junction; ECM; extracellular matrix; EGF; epidermal growth factor; EM; elastic modulus; FBS; fetal bovine seru
Keywords: گلیکوزآمینوگلیکان; Cell penetrating peptides; TAT; Penetratin; POD; Peptide for ocular delivery; PEP-1; HCE: human corneal epithelial cell; Ocular Drug; Delivery; Cornea; Posterior eye segment; In vitro models; Eye drop; Topical instillation; Intravitreal injection; Ocular
Keywords: گلیکوزآمینوگلیکان; MC; microtia chondrocyte; PCL; polycaprolactone; ChiCTR; Chinese clinical trial registry; ICTRP; International Clinical Trial Registry Platform; SOP; standard operating procedures; PGA; polyglycolic acid; PLA; polylactic acid; GMP; good manufacturing proc
Keywords: گلیکوزآمینوگلیکان; ECM; Extracellular matrix; TIMP-1; tissue inhibitor of matrix metalloproteinases-1; HA; hyaluronic acid; IPF; idiopathic pulmonary fibrosis; FDA; Food and Drug Administration; bFGF; basic fibroblast growth factor; IFN-γ; interferon-γ; IL; interleukin; P
Keywords: گلیکوزآمینوگلیکان; ADAMs; a disintegrin and metalloproteinases; ADAMTS; ADAMs with thrombospondin motifs; Col; collagen; CS; chondroitin sulfate; CTGF; connective tissue growth factor; DS; dermatan sulfate; ECM; extracellular matrix; EGF; epidermal growth factor; EMT; epith
Keywords: گلیکوزآمینوگلیکان; HA; hyaluronic acid; Tregs; regulatory T cells; T1DM; type 1 diabetes mellitus; IBD; inflammatory bowel disease; RA; rheumatoid arthritis; MHC; major histocompatibility complex; HLA; human leukocytes antigens; TLRs; toll-loke receptors; PRRs; pattern reco
Keywords: گلیکوزآمینوگلیکان; Case report; Elosulfase alfa; Enzyme replacement therapy; Morquio A syndrome; Mucopolysaccharidosis type IV A; Non-ambulatory; ERT; enzyme replacement therapy; GAG; glycosaminoglycan; GALNS; N-acetylgalactosamine-6-sulfatase; KS; keratan sulfate; 3MSCT; 3
Keywords: گلیکوزآمینوگلیکان; Glycosaminoglycan; Heparan sulfate; Tandem mass spectrometry; Electron transfer dissociation; Divide-and-conquer;
Keywords: گلیکوزآمینوگلیکان; Chondroitin sulfate (PubChem CID: 24766); Heparin (PubChem CID: 25244225); Dermatan sulfate (PubChem CID: 32756); Shellfish; Polysaccharide; HPLC-MS; Glycosaminoglycan;
Keywords: گلیکوزآمینوگلیکان; CK; Creatine kinase; DBS; Dried blood spot; GAA; Alpha-glucosidase; GAG; Glycosaminoglycan; GBA; Beta-glucosidase; IDUA; Alpha-L-iduronidase; IOPD; Infantile-onset Pompe disease; LOPD; Late-onset Pompe disease; LSD; Lysosomal storage disorder; MPS; Mucopo
Keywords: گلیکوزآمینوگلیکان; Chondroitin sulfate; Glycosaminoglycan; Acid hydrolysis; Oligosaccharide; HPLC-MSn;
Keywords: گلیکوزآمینوگلیکان; AD; axial diffusivity; CNS; central nervous system; CSF; cerebrospinal fluid; DTI; diffusion tensor imaging; FA; fractional anisotropy; FLAIR; fluid-attenuated inversion recovery; GAG; glycosaminoglycan; GM; gray matter; HCP; human connectome project; MD;
Keywords: گلیکوزآمینوگلیکان; BAL; bronchoalveolar lavage; BID; [bis in die] twice a day; CS; chondroitin sulphate; CXCL8; , C-X-C motif chemokine 8/interleukin-8; CXCR1/2; chemokine (C-X-C motif) receptor 1/2; EAU; experimental autoimmune uveitis; ELICO; ELISA-like competition assay;
Keywords: گلیکوزآمینوگلیکان; AD; Alzheimer's disease; APC; antigen presenting cell; DC-HIL; HSPG dependent integrin ligand; EAE; experimental autoimmune encephalitis; EC; endothelial cell; ECM; extracellular matrix; GAG; glycosaminoglycan; GBM; glioblastoma; GPI; glycosyl-phosphatidy
Keywords: گلیکوزآمینوگلیکان; Porifera skeleton; Bioactive-biomimetic material; Glycosaminoglycan; Alginate-based film; Environmentally sustainable formulation; Novel wound dressing;
Intelligent substance delivery into cells using cell-penetrating peptides
Keywords: گلیکوزآمینوگلیکان; CPP; cell-penetrating peptide; PTD; protein transduction domain; siRNA; small interfering ribonucleic acid; HIV-1; human immunodeficiency virus 1; Arg; arginine; Lys; lysine; Rn; polyarginine composed of n arginines, where n is natural number; a.a.; amino
Keywords: گلیکوزآمینوگلیکان; ECM; extracellular matrix; GAG; glycosaminoglycan; MMP; matrix metalloproteinase; CS; chondroitin sulfate; ADAMTS; a disintegrin and metalloproteinase with a thrombospondin type-1 motif; PSGL-1; P-selectin glycoprotein-1; TLR; toll-like receptors; TNFα;
Keywords: گلیکوزآمینوگلیکان; Exercise; Aggrecan; Proteoglycan; Glycosaminoglycan; Collagen; Thickness;
Keywords: گلیکوزآمینوگلیکان; 2-DG; 2-deoxy glucose; Akt; protein kinase B; ARDS; acute respiratory distress syndrome; Arg; arginase; BALF; broncho-alveolar lavage fluid; BCG; Bacillus Calmette-Guérin; CD; cluster of differentiation; cGAS; cyclic GMP-AMP synthase; COX-2; cyclooxyge
Probing amylin fibrillation at an early stage via a tetracysteine-recognising fluorophore
Keywords: گلیکوزآمینوگلیکان; Amylin; FlAsH; Fibrillation; Early detection; Amyloid inhibitor; Glycosaminoglycan;
Keywords: گلیکوزآمینوگلیکان; AMI; Acute myocardial infarction; C1-inh; C1-inhibitor; C1s-inh; C1s-inhibitor; C4BP; C4b-binding protein; CK(-MB); creatine kinase (-MB); CPN; carboxypeptidase-N; CR1; complement receptor 1; CVF; cobra venom factor; DDA; disodium disuccinate astaxanthin;
Keywords: گلیکوزآمینوگلیکان; â¢OH; hydroxyl radical; 2,2-BP; 2,2-bipyridyl; ABC; ATP-binding cassette; AIF; apoptosis-inducing factor; AMPK; AMP-activated protein kinase; AMPKK; AMPK kinase; ANT; adenine nucleotide translocase; AP-1; activator protein 1; Apaf-1; protease activating
Keywords: گلیکوزآمینوگلیکان; Glycosylation; O-glycan; N-glycan; Glycosaminoglycan; Metastasis;
Keywords: گلیکوزآمینوگلیکان; BCP; biphasic calcium phosphate; BMMSC; bone marrow-derived mesenchymal cells; CPC; calcium phaosphate cements; DPSC; dental pulp stem cell; ECM; extracellular matrix; EDC; 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride; GAG; glycosaminoglyc
Keywords: گلیکوزآمینوگلیکان; Disc degeneration; Vertebra; Endplate; Intervertebral disc; Nucleus pulposus; Annulus fibrosus; Glycosaminoglycan; Disc space narrowing; Computed tomography;
Keywords: گلیکوزآمینوگلیکان; GAG; glycosaminoglycan; GalNAc; N-acetyl galactosamine; GlcA; D-glucuronic acid; CS; chondroitin sulphate; DS; dermatan sulphate; C4S; chondroitin 4-sulphate; C6S; chondroitin 6-sulphate; DPPH; 1-diphenyl-2-picrylhydrazyl; MTT; [3-(4,5-dimethylthiazol-2-y
Keywords: گلیکوزآمینوگلیکان; Mucopolysaccharidoses; Lysosomal storage diseases; Behavior; Child behavior disorders; Mental disorders; CNS; central nervous system; GAG; glycosaminoglycan; MPS; mucopolysaccharidosis; MPS IH; Hurler syndrome; T-DSM-IV-S; Turgay Diagnostic and Statistica
Keywords: گلیکوزآمینوگلیکان; Glycosaminoglycan; Protein; Interaction; Structural motif; Analytical methods;
Keywords: گلیکوزآمینوگلیکان; CS; chondroitin sulfate; DEJ; dermal-epidermal junction; DS; dermatan sulfate; ECM; extracellular matrix; FGF; fibroblast growth factor; GAG; glycosaminoglycan; HA; hyaluronic acid; GalNAc; galactosamine; GlcNAc; glucosamine; HexUA; hexuronic acid; JAD; (
Keywords: گلیکوزآمینوگلیکان; Digital Image Correlation; Biaxial stretch bioreactor; Strain patterns; Collagen; Glycosaminoglycan;
Keywords: گلیکوزآمینوگلیکان; NGS; next-generation sequencing; WGS; whole-genome sequencing; WES; whole-exome sequencing; AD; Autosomal Dominant; AR; Autosomal Recessive; XLR; X-Linked Recessive; OI; osteogenesis imperfecta; OSMED; oto-spondylo-mega-epiphyseal dysplasia; SADDAN; sever